Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Nov 2 2021

Full Issue

CDC Says Covid Immunity From Shots, Infections Lasts At Least 6 Months

But the Centers for Disease Control and Prevention reported that immunity given by vaccines is more consistent than from an infection, and shots give a "huge boost" of antibodies in people who previously had covid. Separately, a study says three Pfizer shots are 92% more effective than just two.

The Washington Post: CDC Finds Immunity From Vaccines Is More Consistent Than From Infection, But Both Last At Least Six Months 

It’s a question that scientists have been trying to answer since the start of the pandemic, one that is central to the rancorous political debates over coronavirus vaccine policies: How much immunity does someone have after recovering from a coronavirus infection, and how does it compare with immunity provided by vaccination? The Centers for Disease Control and Prevention has weighed in for the first time in a detailed science report released with little fanfare Friday evening. Reviewing scores of research studies and its own unpublished data, the agency found that both infection-induced and vaccine-induced immunity are durable for at least six months — but that vaccines are more consistent in their protection and offer a huge boost in antibodies for people previously infected. (Sun and Achenbach, 11/1)

CIDRAP: Large Study Shows High Protection Of 3 Vs 2 Pfizer COVID Vaccine Doses

A third Pfizer COVID-19 vaccine dose is 92% more effective in reducing severe COVID-related outcomes than two doses of the same vaccine received at least 5 months previously, according to a large real-world study late last week in The Lancet. The study, conducted by researchers with the Clalit Research Institute in Israel and Harvard University, took place from Jul 30 through Sep 23, during Israel's fourth COVID-19 wave, when the Delta (B1617.2) variant was overwhelmingly predominant. (11/1)

KHN: What Do We Really Know About Vaccine Effectiveness? 

The politicization of covid vaccines — and, well, just about everything else having to do with the pandemic — has led to confusion, if not utter fatigue. And some posts circulating on social media — this slickly edited piece on YouTube, for example — seem to build on these feelings, attempting to cast doubt on the effectiveness of the vaccines. This one intersperses comments from White House medical adviser Dr. Anthony Fauci extolling their protectiveness with screenshots of news headlines, starting with those citing 100% effectiveness, then moving through others reporting sharply lower percentages. Set to the rapidly increasing tempo of the orchestral piece “In the Hall of the Mountain King,” the video ends with headlines about drug company profits. (Appleby, 11/2)

In other vaccine development news —

Dallas Morning News: COVID-19 Breakthrough Infections May Be More Serious In Communities Of Color, Researchers Warn

While fully vaccinated people are a small percentage of those who contract COVID-19, some researchers are worried that racial disparities may persist among so-called “breakthrough” infections. One major challenge, these experts said, is that many state and county health departments do not track breakthrough cases. And even when they track breakthrough cases, they often don’t track those cases by race. Last month, in an opinion piece in The Washington Post, two researchers at Boston University and a prominent New York physician warned that the lack of data could hinder public health officials’ efforts to combat the coronavirus, particularly in communities of color that have been hit hardest by COVID-19. (Canales, 11/1)

Axios: The Vaccines Have Kept Older Americans Out Of The Hospital 

The number of COVID-19 hospitalizations among older Americans dropped significantly since the vaccine rollout at the start of the year, new federal data show. The vaccines have worked extremely well for one of the most vulnerable demographics. Roughly 97% of people 65 and older have at least one vaccine dose, and more than 85% of that age group is fully vaccinated, according to the CDC. (Herman, 11/2)

Politico: Pregnant People Were Shut Out Of Covid Vaccine Trials — With Disastrous Results 

The decision to exclude pregnant people from the first wave of Covid-19 vaccine trials created a data gap that inadvertently fueled vaccine hesitancy — in some cases, with deadly consequences. With a lack of concrete data on the vaccines’ safety in pregnant and lactating people when they first became available, trusted sources like the Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists hedged on recommending the shots for those groups, instead advising patients to consult with their doctors. (Gardner, 11/1)

And in updates on the vaccine rollout —

AP: Judge Limits New California Law Protecting Vaccination Sites

A federal judge has thrown out California’s new 30-foot buffer zone designed to restrict protests at coronavirus vaccination sites, though his ruling left in place other parts of a new state law despite arguments that it infringes on free speech. The law that took effect Oct. 8 makes it illegal to come within 30 feet (9.14 meters) of someone at a vaccination site “for the purpose of obstructing, injuring, harassing, intimidating, or interfering with that person.” (Thompson, 11/1)

North Carolina Health News: NC’s Latinos More Vaccinated Than Non-Latinos 

At the beginning of North Carolina’s vaccine rollout, the rate of Latino people getting the shot lagged behind other groups. In March, just 2.5 percent of all vaccines administered were given to Hispanic residents, even though the group accounts for nearly 10 percent of the state’s population and was hit disproportionately hard by the virus. But now, Latino residents are vaccinated at a higher rate than the non-Latino population, according to the most recent data from the state’s Department of Health and Human Services. Statewide, 67 percent of Hispanic residents 12 and older are vaccinated, a rate 10 percent higher than that of North Carolina’s non-hispanic population. (Donnelly-DeRoven, 11/1)

Charleston Gazette Mail: With Few Residents Getting COVID-19 Booster Shots, Justice Says State Will Need More Body Bags

While West Virginia has long held the dubious distinction of having the nation’s lowest COVID-19 vaccination rate, according to the federal Centers for Disease Control and Prevention, state officials on Monday discussed a new form of vaccine hesitancy in the state: Low numbers of fully vaccinated individuals getting booster shots. “A great many people think, ‘I got my two doses, and I’m safe,’ and for a good while they were safe,” Gov. Jim Justice said Monday of the low percentage of West Virginians getting booster shots. “If they don’t get their booster shots, we’re going to need more body bags,” Justice asserted during the state COVID-19 briefing. (Kabler, 11/1)

Stat: Throwing Spaghetti At The Wall To Overcome Covid Vaccine Hesitancy 

One or two donuts, a car, one million dollars, $25, Super Bowl tickets, french fries. There’s a remarkable range of incentives and other methods devised to overcome Covid-19 vaccine hesitancy. While some of these ideas have stuck like spaghetti thrown against a wall, it’s not clear which are most effective. Even when researchers have demonstrated the success of certain strategies, they haven’t been widely adopted. (Gaffney, 11/2)

NPR: 'Vax' Is Oxford's 2021 Word Of The Year

It would have been pretty difficult to get through 2021 without hearing the word "vax" at least once. If last year was marked by the emergence of COVID-19 on a global scale, this one has been all about the new solution to end the pandemic: the vaccines. That's why Oxford Languages, the creator of the Oxford English Dictionary, chose "vax" as its 2021 Word of the Year. "A relatively rare word in our corpus until this year, by September it was over 72 times more frequent than at the same time last year," Oxford said. (Hernandez, 11/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF